Gossamer Bio Management
Management criteria checks 3/4
Gossamer Bio's CEO is Faheem Hasnain, appointed in Nov 2020, has a tenure of 3.42 years. total yearly compensation is $2.10M, comprised of 29% salary and 71% bonuses, including company stock and options. directly owns 2.29% of the company’s shares, worth €3.23M. The average tenure of the management team and the board of directors is 3.1 years and 4.1 years respectively.
Key information
Faheem Hasnain
Chief executive officer
US$2.1m
Total compensation
| CEO salary percentage | 29.0% |
| CEO tenure | 3.4yrs |
| CEO ownership | 2.3% |
| Management average tenure | 3.1yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$607k | -US$180m |
| Sep 30 2023 | n/a | n/a | -US$187m |
| Jun 30 2023 | n/a | n/a | -US$207m |
| Mar 31 2023 | n/a | n/a | -US$221m |
| Dec 31 2022 | US$7m | US$592k | -US$229m |
| Sep 30 2022 | n/a | n/a | -US$230m |
| Jun 30 2022 | n/a | n/a | -US$231m |
| Mar 31 2022 | n/a | n/a | -US$234m |
| Dec 31 2021 | US$5m | US$574k | -US$234m |
| Sep 30 2021 | n/a | n/a | -US$242m |
| Jun 30 2021 | n/a | n/a | -US$240m |
| Mar 31 2021 | n/a | n/a | -US$247m |
| Dec 31 2020 | US$1m | US$72k | -US$243m |
| Sep 30 2020 | n/a | n/a | -US$233m |
| Jun 30 2020 | n/a | n/a | -US$224m |
| Mar 31 2020 | n/a | n/a | -US$202m |
| Dec 31 2019 | US$1m | US$200k | -US$180m |
| Sep 30 2019 | n/a | n/a | -US$164m |
| Jun 30 2019 | n/a | n/a | -US$165m |
| Mar 31 2019 | n/a | n/a | -US$154m |
| Dec 31 2018 | US$19m | US$470k | -US$147m |
Compensation vs Market: Faheem's total compensation ($USD2.10M) is above average for companies of similar size in the German market ($USD691.02K).
Compensation vs Earnings: Faheem's compensation has been consistent with company performance over the past year.
CEO
Faheem Hasnain (65 yo)
3.4yrs
Tenure
US$2,095,988
Compensation
Mr. Faheem Hasnain has been Chief Executive Officer and President at Gossamer Bio, Inc. since November 16, 2020. He serves as Executive Advisor at Vertex Ventures HC since joining the firm on October 29, 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 3.4yrs | US$2.10m | 2.29% $ 3.2m | |
| COO & CFO | 5.9yrs | US$1.29m | 0.21% $ 296.0k | |
| Chief Commercial Officer | less than a year | US$1.33m | no data | |
| Executive Vice President of Technical Operations & Administration | 2.1yrs | US$1.65m | 0.29% $ 409.6k | |
| General Counsel & Secretary | 3.3yrs | no data | no data | |
| Senior Vice President of Human Resources | no data | no data | no data | |
| Chief Medical Officer | no data | US$2.48m | 0.089% $ 126.1k | |
| Senior Vice President of Commercial New Product Planning | 2.1yrs | no data | no data | |
| Executive Vice President of Regulatory Affairs | no data | no data | 0.022% $ 31.2k | |
| Senior Vice President of Biometrics | 3.1yrs | no data | no data | |
| MD & President of Gossamer Bio Ireland | 2.3yrs | no data | no data | |
| Senior Vice President of CMC | 3.1yrs | no data | no data |
3.1yrs
Average Tenure
60yo
Average Age
Experienced Management: 4GB's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 8.5yrs | US$2.10m | 2.29% $ 3.2m | |
| Independent Director | 5.4yrs | US$87.32k | 0.0032% $ 4.5k | |
| Lead Independent Director | 6.3yrs | US$98.82k | 0.017% $ 23.9k | |
| Independent Director | less than a year | US$133.61k | no data | |
| Independent Director | 5.3yrs | US$86.82k | 0% $ 0 | |
| Independent Director | 2.8yrs | US$81.82k | 0.014% $ 20.0k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
4.1yrs
Average Tenure
59.5yo
Average Age
Experienced Board: 4GB's board of directors are considered experienced (4.1 years average tenure).